Companion Diagnostics: In-house vs. Partnerships - What’s the Winning Formula?

Update: 2025-01-06

Description

What does it take to navigate through the complex question of when and with whom to partner for a companion diagnostic?

Join us in yet another invigorating episode at #AxiomCatalystPodcast where Anne Cherry hosts top industry experts, Kara O'Brien and Tricia Carrigan to share invaluable insights on:

✅ Choosing the right technology

✅ Deciding between in-house development and partnerships

✅ Timing your collaborations strategically

✅ Selecting the ideal diagnostic partner

Subscribe now so you don't miss a beat from the #AxiomTable

#CompanionDiagnostics #PrecisionMedicine #PharmaInnovation #PharmaStrategy

Comments

In Channel

What Does Europe’s Biggest Oncology Congress Mean for the Wider World?

2025-11-1356:09

Pre-emptive Medicine in Cardiometabolic Renal Disease

2025-07-1133:58

Rare Disease Day 2025 Voices of Care Shaping Patient Journeys. Episode 4: Prasanna Shirol (Co-founder & Director of ORDI)

2025-02-2619:24

Rare Disease Day 2025 Voices of Care Shaping Patient Journeys. Episode 3: Prof. Dave Pearce (Chair of the IRDiRC)

2025-02-2621:30

Rare Disease Day 2025 Voices of Care Shaping Patient Journeys. Episode 2: Michelle Werner (CEO at Alltrna, CEO-Partner at Flagship Pioneering)

2025-02-2622:49

Rare Disease Day 2025 Voices of Care Shaping Patient Journeys. Episode 1: Dr. John Brandsema MD (Children’s Hospital of Philadelphia)